AstraZeneca CEO reaffirms commitment to China following executive’s detention

NEW YORK — As­traZeneca is not back­ing away from Chi­na de­spite an in­ves­ti­ga­tion in­to its pres­i­dent of Chi­na op­er­a­tions.

As the com­pa­ny re­port­ed its third-quar­ter earn­ings …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.